Superficial Basal Cell Carcinoma: The Flat Red Patch

Superficial basal cell carcinoma (sBCC) is a slow-growing skin cancer that often appears as a flat, red patch on sun-exposed areas. Unlike other forms of basal cell carcinoma, it tends to spread laterally rather than deeply, making it highly treatable if caught early. This article provides a comprehensive overview of sBCC, its clinical features, diagnosis, and the latest treatment options.

What Is Superficial Basal Cell Carcinoma?

sBCC, also known as basal cell carcinoma superficial type, originates from the basal layer of the epidermis. It is the most common subtype in younger patients and often presents on the trunk or extremities. The lesion typically appears as a well-defined, erythematous patch or thin plaque with a slightly rolled border. It may have telangiectasias, crusting, or superficial ulceration. Early recognition is crucial because, although it rarely metastasizes, it can cause local destruction if left untreated.

Clinical Presentation: Why It Looks Like a Flat Red Patch

The typical sBCC appears as a flat, red patch that may be mistaken for eczema, psoriasis, or a fungal infection. It often has a pearly or translucent quality when stretched. Unlike nodular BCC, which forms a dome-shaped papule with ulceration, the superficial variant spreads horizontally along the epidermis. This leads to its characteristic flat appearance. Over time, the patch may enlarge slowly, developing tiny blood vessels (telangiectasias) or a thin crust.

Patients may notice a persistent red spot that does not heal or occasionally bleeds. Because sBCC grows slowly, it can be present for years before medical attention is sought. It's important to differentiate sBCC from other skin lesions. For instance, a solitary red patch on the chest or back that has been present for months warrants a dermatoscopic examination.

Diagnosis and Subtypes

Diagnosis is primarily clinical, aided by dermoscopy. Dermoscopic features of superficial basal cell carcinoma include fine telangiectasias, multiple small erosions, and leaf-like structures. A shave biopsy is often performed to confirm the diagnosis and distinguish it from other BCC subtypes, such as basal cell carcinoma superficial and nodular type mixed forms. Histology shows nests of basaloid cells with peripheral palisading and stromal retraction, but the tumor is confined to the papillary dermis.

It is essential to differentiate superficial BCC from other BCC subtypes because treatment may vary. Nodular BCC, for instance, requires more aggressive surgical removal. In contrast, the treatment for sBCC often includes less invasive modalities.

Treatment Options for Superficial Basal Cell Carcinoma

Multiple effective treatments exist for superficial basal cell carcinoma (sBCC), depending on lesion size, location, and patient preference. The goal is complete removal while preserving cosmetic appearance. Below are the most common approaches:

• Topical 5-fluorouracil (5-FU): A chemotherapy cream applied daily for 3-6 weeks. Efficacy rates exceed 90% for sBCC.
• Imiquimod 5% cream: An immune response modifier applied 5 times weekly for 6 weeks. It stimulates the immune system to destroy cancer cells.
• Photodynamic therapy (PDT): A photosensitizer is applied then activated by light. Excellent for large or multiple lesions, with good cosmetic outcomes.
• Curettage and electrodesiccation: Scraping the tumor followed by burning the base. Suitable for small, low-risk lesions.
• Mohs micrographic surgery: Reserved for high-risk areas (face, eyes, ears) where tissue preservation is critical. Provides the highest cure rate.
• Cryotherapy: Freezing with liquid nitrogen. Effective for very thin lesions but less controlled depth.

For mixed cases of superficial and nodular BCC, treatment often follows the more aggressive nodular protocol. Regular follow-up is essential because sBCC can recur or new lesions can develop, especially in patients with significant sun damage.

Prevention and Prognosis

Since UV radiation is the primary cause, prevention focuses on sun protection: broad-spectrum sunscreen, protective clothing, and avoiding peak sun hours. sBCC has an excellent prognosis if treated early. However, untreated lesions can become invasive and cause significant cosmetic deformity. Patients with a history of one BCC have a higher risk of developing additional BCCs, so routine skin surveillance is key.

In summary, superficial basal cell carcinoma presents as a flat red patch and is highly treatable with a variety of methods. Early diagnosis and appropriate treatment for sBCC lead to excellent outcomes. If you notice a persistent red, scaly spot on your skin, especially in a sun-exposed area, consult a dermatologist promptly.